Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic

Detalles Bibliográficos
Autores principales: Tarantino, Paolo, Trapani, Dario, Curigliano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136890/
https://www.ncbi.nlm.nih.gov/pubmed/32305011
http://dx.doi.org/10.1016/j.ejca.2020.03.023
_version_ 1783518336085131264
author Tarantino, Paolo
Trapani, Dario
Curigliano, Giuseppe
author_facet Tarantino, Paolo
Trapani, Dario
Curigliano, Giuseppe
author_sort Tarantino, Paolo
collection PubMed
description
format Online
Article
Text
id pubmed-7136890
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71368902020-04-07 Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic Tarantino, Paolo Trapani, Dario Curigliano, Giuseppe Eur J Cancer Article Elsevier Ltd. 2020-06 2020-04-06 /pmc/articles/PMC7136890/ /pubmed/32305011 http://dx.doi.org/10.1016/j.ejca.2020.03.023 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Tarantino, Paolo
Trapani, Dario
Curigliano, Giuseppe
Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic
title Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic
title_full Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic
title_fullStr Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic
title_full_unstemmed Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic
title_short Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic
title_sort conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (sars-cov-2)–related disease pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136890/
https://www.ncbi.nlm.nih.gov/pubmed/32305011
http://dx.doi.org/10.1016/j.ejca.2020.03.023
work_keys_str_mv AT tarantinopaolo conductingphase1cancerclinicaltrialsduringthesevereacuterespiratorysyndromecoronavirus2sarscov2relateddiseasepandemic
AT trapanidario conductingphase1cancerclinicaltrialsduringthesevereacuterespiratorysyndromecoronavirus2sarscov2relateddiseasepandemic
AT curiglianogiuseppe conductingphase1cancerclinicaltrialsduringthesevereacuterespiratorysyndromecoronavirus2sarscov2relateddiseasepandemic

Ejemplares similares